Patient Reported Symptoms the First Week After Intensive Care Unit Discharge and up to Hospital Discharge
NCT ID: NCT05266118
Last Updated: 2023-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
177 participants
OBSERVATIONAL
2022-04-19
2023-03-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
COVID-19 Follow up Intensive Care Studies
NCT04460170
Prediction of the Post-intensive Care Syndrome
NCT05690438
The COVID-ICU Healthcare Professional Study
NCT04372056
Recovery After ICU Treatment: A Prospective Cohort Study
NCT02599428
COVID-19 Patients Admitted to the ICU
NCT04816786
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will increase knowledge about symptoms and symptom clusters in ICU patients during the first week after ICU discharge, and at hospital discharge. In these areas, evidence is lacking. This knowledge will help health care providers to optimize and improve patient care and recovery during the first time period after critically illness, by providing more tailored symptom management at the right time in future support strategies and future plans for rehabilitation.
The present study is a single-center study and has a prospective, longitudinal design. A set of different symptoms are measured in 170 former ICU patients the first week after ICU discharge, in addition to a set of cognitive, psychological, and physical symptoms and health state at hospital discharge. We will measure:
1. Totally 32 different symptoms on day 1; day 3; day 5; and day 7 after ICU discharge
2. A set of cognitive (assessing the level of cognitive function), psychological (posttraumatic stress, anxiety, depression), and physical symptoms (activities of daily life) and health status at hospital discharge. The same set of questionnaires will be filled in during ward stay reflecting patient situation one week prior to ICU admittance (used as baseline measures).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Former ICU patients
Participants is former ICU patients, immediately after transferred from ICU to a hospital ward. At least one of these criteria is needed for the participation in the study: ICU stays \> 24 hours; ventilatory support; transferals to other ICU \< 24 hours; continuous infusion of vasoactive substances. In addition, to be included, the patients must be more than 18 years of age; understand and be able to write and read Norwegian; be able to communicate verbally; not have a manifest cognitive deficit; and not being readmitted to ICU \< 72 hours
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ICU stays \> 24 hours
* Ventilatory support
* Transferals to other ICU \< 24 hours
* Continuous infusion of vasoactive substances
Exclusion Criteria
* Not able to communicate verbally
* A manifest cognitive deficit (e.g., dementia or delirium)
* Re-admission to ICU \< 72 timer
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Norwegian Nurses Organisation
OTHER
Ostfold Hospital Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brita Fosser Olsen, RN,PhD
Role: PRINCIPAL_INVESTIGATOR
Østfold Hospital Trust Postbox 300, 1714 Grålum, Norway
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ostfold Hospital Trust
Sarpsborg, Gralum, Norway
Østfold Hospital Trust
Sarpsborg, Gralum, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
361816
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.